Littleton, MA, United States of America

Aleksandr V Yurkovetskiy

USPTO Granted Patents = 31 

 

 

Average Co-Inventor Count = 6.1

ph-index = 9

Forward Citations = 269(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Aleksandr V Yurkovetskiy - Innovator in Antibody-Drug Conjugates

Introduction

Aleksandr V Yurkovetskiy is a prolific inventor based in Littleton, MA, with an impressive portfolio of 31 patents. His work primarily focuses on advancements in antibody-drug conjugates, which are pivotal to therapeutic and diagnostic applications in the medical field.

Latest Patents

Yurkovetskiy's recent patents reflect his dedication to enhancing drug delivery systems through innovative scientific approaches. His notable patents include:

1. **Peptide-Containing Linkers for Antibody-Drug Conjugates**: This patent discusses antibody-drug conjugates that incorporate peptide-containing linkers. It outlines their use as therapeutics and diagnostics, as well as methods to utilize these linkers in conjunction with targeting moieties and drugs.

2. **Pyrrolobenzodiazepine Antibody Conjugates**: This work details antibody-drug conjugates that utilize pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) drug moieties, highlighting their therapeutic and diagnostic potential.

Career Highlights

Throughout his career, Yurkovetskiy has made significant strides in the biotechnology industry, particularly during his tenure at companies like Mersana Therapeutics, Inc. and Asana Biosciences, LLC. His expertise in the development of conjugate therapies has positioned him as an influential figure in the field.

Collaborations

Yurkovetskiy has collaborated with various professionals to further his research and innovation. Notable coworkers include Timothy B Lowinger and Mao Yin, who have contributed to the success of his projects and patents.

Conclusion

Aleksandr V Yurkovetskiy continues to be a vital contributor to the field of biotechnology with his extensive patent portfolio and collaborative efforts. His dedication to advancing antibody-drug conjugates is making a lasting impact on the future of medical therapeutics and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…